Open AccessPeritoneal carcinomatosis in colorectal cancer: Defining predictive factors for successful cytoreductive surgery and hyperthermic intraperitoneal chemotherapy – A pilot study
Author(s) -
Ahmed M. Mahmoud,
Yahia Ismail,
Alaadin Hussien,
Yasser Debaky,
Iftekhar Ahmed,
Hisham S. Wahba Mikhael,
Manar M. Moneer
Publication year - 2018
Publication title -
journal of egyptian national cancer institute/journal of the egyptian national cancer institute
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.398
H-Index - 22
eISSN - 2589-0409
pISSN - 1110-0362
DOI - 10.1016/j.jnci.2018.10.004
Subject(s) - medicine , hyperthermic intraperitoneal chemotherapy , ascites , conventional pci , colorectal cancer , cytoreductive surgery , chemotherapy , oncology , cancer , surgery , gastroenterology , ovarian cancer , myocardial infarction
Peritoneal carcinomatosis originating from colorectal cancer (PC-CRC) carries a dismal prognosis. Cytoreductive surgery (CRS) combined with hyperthermic intraperitoneal chemotherapy (HIPEC) have been offered to those patients with substantial health and economic burden, nevertheless not all patients are fitting this treatment modality and outcome is generally still poor.